TERT and central nervous system cancer: Additionally, Fukuma et al. were able to successfully classify gliomas with IDH-wildtype, IDH/TERT promoter co-mutation as well as IDH-mutant/TERT-wildtype genomic signatures with a 63.1% accuracy utilizing a pre-trained convolutional neural network [53].